Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4369552 | 0.82 | KCNN4 (0.57) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL25401154 | 0.78 | KCNN4 (0.52) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL14354433 | 0.77 | MAPT (0.50) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL14881144 | 0.77 | KCNN4 (0.50) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL6016877 | 0.74 | MAPT (0.63) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8995888 | 0.72 | KCNN4 (0.53) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL18650576 | 0.72 | CES1 (0.53) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL27508980 | 0.71 | KCNN4 (0.62) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL3534906 | 0.70 | KCNN4 (0.47) | KCNN4HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL18339128 | 0.70 | MAPT (0.48) | KCNN4HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1582201-B1 | Use of asymmetrically substituted triazine derivatives for solubilising or for enhancing the solubilisation of symmetrically substituted triazine derivatives in oil compositions | BEIERSDORF AG (DE) | 2013-08-21 | — | — | EP | disclosed |
| EP-1582201-A2 | Use of asymmetrically substituted triazine derivatives for solubilising or for enhancing the solubilisation of symmetrically substituted triazine derivatives in oil compositions | Beiersdorf AG (DE) | 2005-10-05 | — | — | EP | disclosed |
| EP-1559413-A2 | Stable cosmetic or dermatologic compositions in the form of W/O emulsions containing asymmetrically substituted triazine derivatives | Beiersdorf AG (DE) | 2005-08-03 | — | — | EP | disclosed |
| EP-0950397-B1 | Use of asymmetrically substituted triazine derivatives for solubilising or for enhancing the solubilizing of symmetrically substituted triazine derivatives | BEIERSDORF AG (DE) | 2005-07-27 | — | — | EP | disclosed |
| EP-1071394-B1 | USE OF UNSYMMETRICALLY SUBSTITUTED TRIAZINE DERIVATIVES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR MAINTAINING THE UROCANIC ACID STATUS OF THE SKIN | BEIERSDORF AG (DE) | 2004-07-14 | — | — | EP | disclosed |
| US-6372199-B1 | Use of unsymmetrically substituted triazine derivatives in cosmetic or dermatological preparations for maintaining the urocanic acid status of the skin | BEIERSDORF AG (DE) | 2002-04-16 | — | — | US | disclosed |
| EP-0950397-A1 | Use of asymmetrically substituted triazine derivatives for solubilising or for enhancing the solubilizing of symmetrically substituted triazine derivatives | Beiersdorf Aktiengesellschaft (DE) | 1999-10-20 | — | — | EP | disclosed |
| EP-0950396-A1 | Stable cosmetic or dermatologic compositions in the form of W/O emulsions containing asymmetrically substituted triazine derivatives | Beiersdorf Aktiengesellschaft (DE) | 1999-10-20 | — | — | EP | disclosed |